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MYELOMATOSIS results from the abnormal proliferation of plasma cells derived
from reticulum cells, usually within the bone marrow but occasionally from those
outside. Various clinical manifestations may arise. In a review of 188 cases of
myelomatosis, Innes and Newall (1961) classified them into 4 main groups:
1. Solitary myeloma, where a bone focus is present without disease elsewhere;
2. Multiple myeloma, where there are scattered foci of plasma cell proliferation
in several or many bones;
3. Diffuse myelomatosis, where there is a diffuse infiltration ofthe bone marrow
by plasma cells without discrete tumour formation, and
4. Extramedullary plasmacytoma, the rarest group, where the primary focus
commences in reticulum cells outside the bone marrow.
They considered these different manifestations were the result ofthe same basic
pathological process. Others have suggested that extramedullary plasmacytoma
be considered a separate entity because of the better prognosis and usual absence
of haematological, biochemical and radiological changes found in myelomatosis
(Dolin and Dewar, 1956; Martinson and Pulvertaft, 1967).
It is recognised, however, that extramedullary plasmacytoma, like solitary
myeloma, may develop generalised manifestations, but it is not realised how
frequently extramedullary lesionsoccurinthosewithmultiple myeloma. Previous
reports have described soft tissue masses in multiple myeloma (Gordon and Churg,
1949; Hayes, Bennett and Heck, 1952; Fraser, Schuh and Mullen, 1966) and here
a patient is described in whom several tumour masses developed late in the
disease. The first ofthese occurred in the breast, which is an unusual site.
CASE HISTORY
Mrs. H. K., aged 51, was admitted to Westminster Hospital in September 1962,
with backache of 4 months' duration. A diagnosis ofmultiple myelomatosis was
made and confirmed by the following investigations.
Haemoglobin 65 %; white blood count 4700/c.mm.; sedimentation rate
67 mm./hour; packed cell volume 24%; serum iron 64,ug./100 ml. Bone
marrow puncture showed a marked excess of plasma cells (Fig. 1). The serum
proteins were greater than 8-6 g./100 ml., and an electrophoretic strip showed an
abnormal band in the y-globulin fraction, which was markedly increased, and
there was some increase in Al2 macroglobulin. The serum calcium was 12*9 mg./
100 ml., phosphate 3*6 mg./100 ml. and blood urea 74 mg./100 ml. The liver
function tests were normal except the mercuric chloride and zinc sulphate were inI. L. CRAFT
excess of 30 units. Bence-Jones protein was not found in the urine. Multiple
osteolytic lesions were seen onthe X-ray ofthe skull, ribs, spine, pelvis, humeri and
femora. There was a large deposit in the left superior pubic ramus, some rib
fractures and widespread collapse and osteoporosis ofthe spine.
She was treated with intravenous cyclophosphamide, blood transfusions, and
radiotherapy to the dorsal spine (2600 r.), and to the left side ofthe pelvis (3000 r.).
Her clinical and biochemical states improved and she was discharged on a main-
tenance dose of oral cyclophosphamide 100 mg. daily, for 5 days a week.
She remained well until July 1963 when a painful, tender swelling of the
sternum appeared. This resolved with radiotherapy (3000 r.). In August 1963
examination of the serum proteins showed the J2 macroglobulin had disappeared
and there was a marked fall in the abnormal band, though no significant change in
the y-globulin level. Three years later she developed pain in the left hip and
X-rays showed some extension of the disease in the pelvis and femora. Radio-
therapy to the left hip (2500 r.) relieved the pain. She was still being maintained
on the same dose of cyclophosphamide.
In October 1965 she was re-admitted with a lump in her right breast (Fig. 2).
This had been present for 2 months, was painless and had progressively increased
in size. On examination there was a firm, non-tender mass, three inches in
diameter, involving all four quadrants of the breast. Its surface was nodular.
There was one small area of skin attachment but no deep fixation. There was
no axillary lymphadenopathy. A drill biopsy was performed. Histology was ofa
cellular tumour which was made up of masses of plasma cells (Fig. 3), many of
which showed bizarre features; the appearances were those of a plasmacytoma.
A course of radiotherapy (3800 r.) was given to the breast and the mass dis-
appeared (Fig. 4).
She was admitted for the last time on December 17, 1965 with malaise, pro-
gressive dysuria culminating in retention, and because of the appearance of
myelomatous deposits in her neck. The retention, which required permanent
catheter drainage, was secondary to a pelvic mass felt at the vault of the vagina.
One week after her admission haematuria developed which persisted until her
death. Cystoscopy showed the bladder wall was greatly haemorrhagic, with
bleeding from a multitude of capillaries. Radiotherapy was given in an attempt
to reduce the size of the pelvic mass (anterior pelvis 4144 r., posterior pelvis
1958 r.). The oral cyclophosphamide was stopped on admission and changed to
oral methotrexate 5 mg./day but this had to be discontinued after 5 days because
of leucopenia. The neck deposits disappeared with radiotherapy (1800 r. to
both sides and posterior aspect) but further courses were required for deposits
which appeared over the left sterno-clavicular joint (2000 r.), in the right thigh
(1200 r.) and in the left axilla (600 r.). The patient became jaundiced and
deteriorated. The haematuria continued and the anaemia became progressive.
EXPLANATION OF PLATES
FIG. 1.-Photomicrograph of sternal marrow showing excess of plasma cells. x 490.
FIG. 2.-Enlargement ofright breast due to extramedullary plasmacytoma.
FIG. 3.-Photomicrograph of drill biopsy showing plasma cells, some with atypical features.
x490.
FIG. 4.-Complete disappearance of mass following radiotherapy.
502BRITISH JOURNAL OF CANCER.
I
2
Craft.
VOl. XXI, NO. 3.Vol. XXI, No. 3.
.I_ *} Id
BRITISH[ JOURNAL OF CANCER.
p 4
p:
..5lF' *]p
3
4
Craft.EXTRAMEDULLARY LESIONS IN MYELOMATOSIS
A vesico-vaginal fistula developed 1 week before her death on March 3. 1966.
A post-mortem was not performed.
DISCUSSION
Extramedullary plasmacytomas, unassociated with multiple myeloma, may be
single or multiple and arise in almost any tissue in the body. The most frequent
sites in which they are found are the upper nasal passages and oral cavitv. Dolin
and Dewar (1956) in a review of 161 cases of primary extramedullary plasma-
cytomas noted 78 % occurred in this situation and recently Todd (1965) reported
21 cases ofwhom 16 (76%0) had plasmacytomas in the upper air passages.
There is no such predilection of site when these tumour masses occur in those
with multiple myeloma, but there is a tendency for them to develop in those
organs with the greatest number of reticulo-endothelial elements, i.e. the liver,
spleen and lymph nodes (Hayes et al., 1952). The other tissues in which lesions
have been found include the kidney, lung, pleura, heart, pericardium, pancreas,
adrenal, retroperitoneal tissues, peritoneum, gastrointestinal tract, bladder, testis,
ovary, thyroid, skin, subcutaneous tissues and skeletal muscles. The breast is a
most unusual site and in a review of 182 cases of multiple myeloma with extra-
medullary involvement (Hayes et al., 1952) no case with a breast lesion was
reported. Primary extramedullary plasmacytomas have been described in the
breast on a few occasions (Vasiliu and Popa, 1928; Cutler, 1934; Innes and
Newall, 1961).
The frequency with which these lesions occur in those with multiple myeloma
has been assessed from autopsy studies; Hayes et al. (1952) found evidence of
involvement in 71 %; Gordon and Churg (1949) in 73 % and Innes and Newall
(1961) in 50 % of cases where autopsy was performed. The nature of this involve-
ment varies from microscopical infiltration to gross enlargement of organs and
actual tumour formation. The latter was reported in 31 % of autopsies by Innes
and Newall (1961). It would appear that it is common for extramedullary
involvement to occur in multiple myeloma, late in the disease. Tumour formation
although not very rare, is usually unrecognised clinically because of the tendency
to occur within the thoracic and abdominal cavities. It is not known exactly how
these lesions arise, whether by autochthonous growth or by spread of myeloma
cells from the bone marrow. It has been noted histologically that there is a
tendency for more primitive reticulum cells to be present in the lesions outside
the marrow than in those within.
The prognosis of multiple myeloma with soft tissue lesions is invariably poor,
there were no patients who survived 5 years in the series reported by Innes and
Newall (1961) and only 6 % in that reported by Todd (1965). A poor prognosis
is not necessarily the case for those with primary extramedullary plasmacytomas
as it is impossible to forecast which of these will develop generalised disease.
Some cases have been followed for more than 10 years without recurrence or dis-
semination (Jaegar, 1941; Figi, Bryders and Havens, 1945; Stout and Kenney,
1949; Dolin and Dewar, 1956).
SUMMARY
The frequency with which extramedullary lesions occur in myelomatosis is
discussed, and a patient is described in whom several soft tissue masses appeared
late in the course of the disease.
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